At the request of several provincial scleroderma (Scl) associations, I am pleased to provide an overview of recent research carried out under the University of Montreal Scleroderma Research Chair.
For the past several years, an advanced program of translational research on Scl is in progress in Montreal at the Research Center of the Centre Hospitalier de l’Université de Montréal (CHUM). This program results from a close collaboration between the Laboratory for Immunoregulation, directed by Marika Sarfati, MD, PhD, an immunologist and basic scientist, and the Laboratory for Research on Autoimmunity, directed by the undersigned, a rheumatologist and clinician researcher specialized in the care of Scl patients.